GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (XKRX:078160) » Definitions » PS Ratio

Medipost Co (XKRX:078160) PS Ratio : 2.22 (As of Apr. 30, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Medipost Co PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Medipost Co's share price is ₩7070.00. Medipost Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩3,178.31. Hence, Medipost Co's PS Ratio for today is 2.22.

The historical rank and industry rank for Medipost Co's PS Ratio or its related term are showing as below:

XKRX:078160' s PS Ratio Range Over the Past 10 Years
Min: 2.14   Med: 11.39   Max: 26.93
Current: 2.23

During the past 13 years, Medipost Co's highest PS Ratio was 26.93. The lowest was 2.14. And the median was 11.39.

XKRX:078160's PS Ratio is ranked better than
82.98% of 993 companies
in the Biotechnology industry
Industry Median: 9.09 vs XKRX:078160: 2.23

Medipost Co's Revenue per Sharefor the three months ended in Dec. 2023 was ₩499.80. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩3,178.31.

Warning Sign:

Medipost Co Ltd revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Medipost Co was -32.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was -9.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 8.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was 1.50% per year.

During the past 13 years, Medipost Co's highest 3-Year average Revenue per Share Growth Rate was 42.70% per year. The lowest was -17.30% per year. And the median was 4.95% per year.

Back to Basics: PS Ratio


Medipost Co PS Ratio Historical Data

The historical data trend for Medipost Co's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipost Co PS Ratio Chart

Medipost Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.84 11.06 6.20 4.32 4.05

Medipost Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.32 3.89 3.81 2.28 4.05

Competitive Comparison of Medipost Co's PS Ratio

For the Biotechnology subindustry, Medipost Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medipost Co's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medipost Co's PS Ratio distribution charts can be found below:

* The bar in red indicates where Medipost Co's PS Ratio falls into.



Medipost Co PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Medipost Co's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=7070.00/3178.305
=2.22

Medipost Co's Share Price of today is ₩7070.00.
Medipost Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3,178.31.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Medipost Co  (XKRX:078160) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Medipost Co PS Ratio Related Terms

Thank you for viewing the detailed overview of Medipost Co's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medipost Co (XKRX:078160) Business Description

Traded in Other Exchanges
N/A
Address
21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR
Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (XKRX:078160) Headlines

No Headlines